P164 Hairy cell leukemia complicated with acromegaly: a case report
β Scribed by Zs. Nagy; K. Balassa; J. Demeter
- Book ID
- 104323216
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 48 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0268-960X
No coin nor oath required. For personal study only.
β¦ Synopsis
cursor was set to the same position in each sample, where 5% of T/NK cells were Zap-70 negative. Zap-70 and CD38 labeling was determined on CD19+ cells. Results: With dichotomized evaluation of CD38 and Zap-70 expression 70% of the cases showed concordant results: 32% were Zap-70+/CD38+ and 38% were Zap-70 /CD38 . In 30% of the patients results were discordant. Parallel examinations of bone marrow (BM) and peripheral blood (PB) samples were compared in 18 patients. In all discordant cases (6 patients) Zap-70 values showed positivity in the BM specimens while the PB samples were negative. Longitudinal examinations were carried out 2 to 9 times few months apart in 24 patients (92 tests). Significant variability of the Zap-70 results was found in those cases where the test was repeated more than two times in contrast to CD38 expression which remained stable. The unstable Zap-70 results were not in connection with treatment protocol or CD38 bimodality. Conclusion: Expression of CD38 seems to be more stable over time than
π SIMILAR VOLUMES
Central nervous system involvement has not previously been described in patients with hairy cell leukemia (HCL). A patient is reported who presented with meningeal involvement as his initial symptom of HCL. Diagnosis was established by morphologic and cytochemical studies of his cerebrospinal fluid
immunmodulant therapy was begun. We started steroid, cyclosporine and thalidomide therapy. The control abdominal and pelvic CT showed small residual tumor on the bladder. Repeated surgery was done, residual was taken out. At this time histological examination showed transient type between plasma cel
A patient with leukemic reticuloendotheliosis is described who two years following splenectomy developed massive retroperitoneal, abdominal, and mediastinal lymphadenopathy. Therapeutic intervention was necessary because the bulky tumor masses produced disabling pain in the back and chest regions. L